Explorerโ€บPharmaceutical Researchโ€บBiochemistry
Research PaperResearchia:202609.30023

Benchmarking graph-based models for in-silico toxicity prediction in drug discovery

Noel Suarez-Barro

Abstract

Drug discovery is a costly and high-risk process, where toxicity-related failures remain a major cause of attrition in both preclinical and clinical stages. As a result, accurate early prediction of chemical toxicity is essential to reduce downstream costs and improve compound prioritization. In this context, graph deep learning (GDL) has emerged as a powerful paradigm for toxicity prediction, leveraging molecular graph representations to learn directly from chemical structure with improved expr...

Submitted: September 30, 2026Subjects: Biochemistry; Pharmaceutical Research

Description / Details

Drug discovery is a costly and high-risk process, where toxicity-related failures remain a major cause of attrition in both preclinical and clinical stages. As a result, accurate early prediction of chemical toxicity is essential to reduce downstream costs and improve compound prioritization. In this context, graph deep learning (GDL) has emerged as a powerful paradigm for toxicity prediction, leveraging molecular graph representations to learn directly from chemical structure with improved expressivity over traditional approaches. Despite the growing number of proposed models, current literature-based comparisons are often difficult to interpret due to inconsistencies in datasets, preprocessing pipelines, and evaluation protocols. To address this limitation, we introduce a unified and standardized benchmarking framework for GDL-based toxicity prediction. We systematically evaluate more than 20 representative approaches under consistent experimental conditions and across multiple datasets and partitioning strategies, enabling a fair and reproducible comparison of model performance. In addition, we complement this empirical study with a structured literature analysis to contextualize existing methodological trends and performance claims. Our results provide a clearer and more reliable assessment of the current state of the field, highlighting both the strengths and limitations of existing graph-based approaches. To support transparency and reproducibility, we release our benchmarking framework as open-source software https://gitlab.citius.gal/noel.suarez/benchtox, allowing the community to evaluate and compare models under consistent conditions.


Source: arXiv:2609.37555v1 - http://arxiv.org/abs/2609.37555v1 PDF: https://arxiv.org/pdf/2609.37555v1 Original Link: http://arxiv.org/abs/2609.37555v1

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
View Source PDF
Submission Info
Date:
Sep 30, 2026
Topic:
Pharmaceutical Research
Area:
Biochemistry
Comments:
0
Bookmark